InsidersTradesSigma
Follow the 金河生物 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 金河生物 has recorded 3 reports. Market capitalisation: €3.7bn. The latest transaction was reported on 19 August 2025 (Sale). Among the most active insiders: 内蒙古金河控股有限公司. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
金河生物 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XSHE. Se centra en el desarrollo y la producción de productos biológicos.